Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Property, plant and equipment

v3.22.1
Property, plant and equipment
12 Months Ended
Dec. 31, 2021
Disclosure of detailed information about property, plant and equipment [abstract]  
Property, plant and equipment

 

11. Property, plant and equipment

 

   

Facility & Scientific Equipment

£

   

Computer Equipment

£

   

Office Equipment

£

   

Total

£

 
Cost                                
At January 1, 2020     4,850,526       319,637       84,044       5,254,207  
Additions     32,311       1,414       1,176       34,901  
At December 31, 2020     4,882,837       321,051       85,220       5,289,108  
Additions     6,825       12,097       1,111       20,033  
At December 31, 2021     4,889,662       333,148       86,331       5,309,141  
                                 
Depreciation                                
At January 1, 2020     1,211,170       180,036       27,499       1,418,705  
Charge for the year     721,642       88,356       16,752       826,750  
At December 31, 2020     1,932,812       268,392       44,251       2,245,455  
Charge for the year     703,960       44,326       16,745       765,031  
At December 31, 2021     2,636,772       312,718       60,996       3,010,486  
                                 
Net book value                                
At December 31, 2021     2,252,890       20,430       25,335       2,298,655  
                                 
At December 31, 2020     2,950,025       52,659       40,969       3,043,653  

 

The depreciation charge for the year is recognized within research and development and administrative expenses in the statements of comprehensive loss. Refer to Note 5 for further details.

 

The net book value of property, plant and equipment held under sale and leaseback arrangements is £325,935 (2020: £535,456).

 

 

TC BIOPHARM (HOLDINGS) PLC

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)